Helen Marie Pettinati researcher
Pettinati, Helen M. (Helen Marie)
Pettinati, Helen M.
VIAF ID: 23609175 (Personal)
Permalink: http://viaf.org/viaf/23609175
Preferred Forms
- 100 0 _ ‡a Helen Marie Pettinati ‡c researcher
-
- 100 1 _ ‡a Pettinati, Helen M.
- 100 1 _ ‡a Pettinati, Helen M.
-
- 100 1 0 ‡a Pettinati, Helen M. ‡q (Helen Marie)
-
- 100 1 _ ‡a Pettinati, Helen M. ‡q (Helen Marie)
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
A double-blind, placebo-controlled trial of modafinil for cocaine dependence | |
The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes | |
Effects of alcoholism typology on response to naltrexone in the COMBINE study | |
The effects of naltrexone on alcohol and cocaine use in dually addicted patients | |
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial | |
Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT | |
Extended-Release Injectable Naltrexone (XR-NTX) With Intensive Psychosocial Therapy for Amphetamine-Dependent Persons Seeking Treatment: A Placebo-Controlled Trial. | |
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients | |
Gender and Psychiatric Comorbidity: Impact on Clinical Presentation of Alcohol Dependence | |
Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study | |
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence | |
Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. | |
Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence | |
HIV-risk behaviors among a middle class population: a preliminary investigation among adolescent vs. adult substance users | |
Hypnosis and memory | |
Hypnosis in the treatment of anorexic and bulimic patients | |
Impulsivity and substance abusers: changes with treatment and recovery | |
Incidence of personality disorders in cocaine vs. alcohol-dependent females. | |
Increased Incidence of Missed Seizures During ECT in the Elderly Male | |
Initial Impression of Two New Brief-Pulse Electroconvulsive Therapy Machines | |
Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence | |
Inpatient vs outpatient treatment for substance dependence revisited | |
Letter to the editor in regard to Timko, DeBenedetti, Moos, and Moos (2006): "Predictors of 16-year mortality among individuals initiating help-seeking for an alcoholic use disorder". | |
Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone | |
Long term outcome in working and homemaking alcoholic women | |
Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. | |
Low use of neuroleptic drugs in the treatment of psychotic major depression | |
Measuring hypnotizability in psychotic patients | |
Memory complaints in depressed geriatric inpatients. | |
Memory self-ratings before and after electroconvulsive therapy: depression-versus ECT induced. | |
Meta-Analysis of Effects of Electrode Placements | |
Meta-Analytical Approach to Reconciling Discrepancies in Efficacy between Bilateral and Unilateral Electroconvulsive Therapy. | |
Missed and brief seizures during ECT: differential response between unilateral and bilateral electrode placement | |
The natural history of alcoholism over four years after treatment | |
The natural history of outpatient alcohol and drug abuse treatment in a private healthcare setting. | |
Neuronal calcium sensor-1 and cocaine addiction: a genetic association study in African-Americans and European Americans | |
New pharmacotherapies for treating the neurobiology of alcohol and drug addiction. | |
Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence | |
OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach | |
Patient attitudes toward electroconvulsive therapy | |
A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention | |
Posthypnotic amnesia: evaluation of selective recall of successful experiences | |
Predicting treatment response to naltrexone: the influence of craving and family history | |
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action | |
Psychometric properties of the Penn Alcohol Craving Scale. | |
Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study | |
Relationship between medication adherence and treatment outcomes: the COMBINE study. | |
The Relationship of Axis II Personality Disorders to Other Known Predictors of Addiction Treatment Outcome | |
Reliability and validity of the aggregate method of determining number of cigarettes smoked per day | |
Resistance to antidepressant medications and short-term clinical response to ECT | |
Results of an initial clinical trial of varenicline for the treatment of cocaine dependence | |
The Role of Female Occupation in Severity of Alcohol-Related Problems | |
Selectivity in memory during posthypnotic amnesia, 1979 | |
Sertraline treatment of co-occurring alcohol dependence and major depression | |
Speed of ECT? | |
The status of disulfiram: a half of a century later | |
The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking | |
The therapeutic alliance in medical-based interventions impacts outcome in treating alcohol dependence | |
The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes | |
Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence | |
Using acquired knowledge and new technologies in alcoholism treatment trials | |
Vasopressin for ECT-induced memory impairment: a placebo-controlled comparison. |